← Research library

Testoluten: institute clinical report (commercially hosted translation)

Comparison in people · 2011

What was studied
36 men aged 47–65: 22 adjunctive preparation, 14 nonhormonal-care controls
Main finding
The report describes hormone and self-reported symptom changes with adjunctive treatment.

Study data at a glance

Participants or experimental model
36 men aged 47–65: 22 adjunctive preparation, 14 nonhormonal-care controls
Reported results
The report describes hormone and self-reported symptom changes with adjunctive treatment.
Study limitations and source details

Study limitations

  • Commercial reproduction: signed original, protocol and translation accuracy have not been authenticated.
  • Allocation and blinding are unclear; testosterone units differ between the table and prose, and fertility benefit was not established.
  • Short follow-up and incomplete adverse-event methods do not establish safety; independent replication and present-day product equivalence remain unverified.

Related publications may describe some of the same participants or experiments.

Source details

Institute report — commercial reproduction · PDF

Brochure PDF pp. 68–70: methods/results text checked; selected population/table pages visually inspected. This is a provenance check, not authentication of the institute original.

Report reproduction reviewed

Sources checked

Citation

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

Human comparative studyFull text available

St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution). Testoluten: institute clinical report (commercially hosted translation) Institute-attributed report, 2011; commercially hosted brochure pp. 68–70

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards